Bristol-Myers Squibb Co

S&P 500 Large-Cap Stocks Blue Chip Stocks Pharmaceutical Stocks Healthcare Stocks Best Dividend Stocks Highest Dividend Yield

$58.94

+1.55 (+2.70%)

As of Mar 25, 9:31 PM ET ·

Financial Highlights (FY 2026)

Revenue

47.94B

Net Income

7.02B

Gross Margin

72.6%

Profit Margin

14.6%

Rev Growth

+1.5%

D/E Ratio

2.44

Revenue & Net Income

Margin Trends

	FY 2026	FY 2025	FY 2024	FY 2023
Gross Margin	72.6%	72.6%	59.2%	59.2%
Operating Margin	21.5%	19.3%	22.1%	21.3%
Profit Margin	14.6%	13.9%	20.8%	23.5%

Income Statement

	FY 2026	FY 2025	FY 2024	FY 2023
Revenue	47.94B	47.25B	47.91B	45.13B
Gross Profit	34.81B	34.31B	28.35B	26.71B
Operating Income	10.31B	9.14B	10.61B	9.60B
Net Income	7.02B	6.22B	9.95B	10.61B
Gross Margin	72.6%	72.6%	59.2%	59.2%
Operating Margin	21.5%	19.3%	22.1%	21.3%
Profit Margin	14.6%	13.9%	20.8%	23.5%
Rev Growth	+1.5%	+1.5%	+15.6%	-1.5%

Balance Sheet

	FY 2026	FY 2025	FY 2024	FY 2023
Total Debt	41.35B	41.35B	44.69B	49.22B
Total Equity	16.93B	16.93B	47.12B	45.92B
D/E Ratio	2.44	2.44	0.95	1.07

Cash Flow

	FY 2026	FY 2025	FY 2024	FY 2023
EBITDA	13.60B	12.73B	15.42B	13.24B
Free Cash Flow	—	—	6.08B	6.45B